Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rua Bioscience Limited Report Publication Announcement 2021

Sep 17, 2021

66262_rns_2021-09-17_3640277f-48b2-4642-9a36-a63835b3e59e.pdf

Report Publication Announcement

Open in viewer

Opens in your device viewer

==> picture [133 x 76] intentionally omitted <==

MARKET ANNOUNCEMENT

FOR PUBLIC RELEASE NZX Limited Wellington

Friday 17 September 2021

Rua Bioscience Limited Releases Annual Report for Year Ended 30 June 2021

Rua Bioscience (NZX:RUA) today released its Annual Report for the 12 months ended 30 June 2021 (FY21).

In our report, we review the strides we have made in the past 12 months, outline our current performance, and share our aspirations for the future. We'll give you insight into our industry and the ever-changing environment within which we operate as an ambitious medicinal cannabis start-up. We'll also explore our deep connection to Te Tairāwhiti, the responsibilities we carry as a company established to impact our people and our whenua positively.

The Annual Report is available now on the Rua website www.ruabio.com/investors. Those who have requested it, will receive a hard copy in the post in due course.

ENDS

For more information, please visit www.ruabio.com or contact: Media

Kerry Donovan Communications Manager +64 (21) 128 7689 [email protected]

Investors

Hamish White Chief Financial Officer +64 (21) 050 5795 [email protected]

About Rua Bioscience

Rua Bioscience is a New Zealand pharmaceutical company aiming to produce cannabinoid derived medicines for both export and local markets. Rua has been an early mover in the sector and was the first private company in New Zealand to receive a licence to cultivate Cannabis for research purposes. Founded in 2017 in Ruatorea as a subsidiary of charitable company Hikurangi Enterprises Limited, Rua is underpinned by its mission to heal the people and heal the land. It is committed to New Zealand's Te Tairāwhiti (East Coast) region and its local community. The Company has completed facilities for cultivation and manufacturing and is currently going through the GMP certification process. www.ruabio.com

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com